NextCell Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Market Capitalization	117	81	130	93	124	218
Market Cap Growth	53.87%	-37.52%	40.40%	-25.00%	-43.31%	-56.21%
Enterprise Value	85	43	114	72	61	111
Last Close Price	1.05	0.73	1.17	1.27	3.60	6.35
PS Ratio	12.65	8.28	11.78	8.23	8.87	35.05
PB Ratio	2.13	1.61	1.96	1.37	1.63	1.89
P/TBV Ratio	2.13	1.61	1.96	1.37	1.63	1.89
EV/Sales Ratio	9.16	4.34	10.27	6.39	4.34	17.86
Net Debt / Equity Ratio	-0.59	-0.51	-0.58	-0.69	-0.66	-0.84
Net Debt / EBITDA Ratio	0.82	0.70	1.16	1.11	1.23	2.81
Net Debt / FCF Ratio	0.73	0.56	0.90	1.24	1.04	2.37
Asset Turnover	-	-	0.14	0.13	0.13	0.04
Inventory Turnover	-	-	17.24	22.79	14.12	-
Quick Ratio	4.87	3.92	8.05	5.06	5.32	14.40
Current Ratio	4.90	5.16	10.02	6.15	6.67	15.40
Return on Equity (ROE)	-	-	-52.46%	-58.55%	-41.63%	-26.02%
Return on Assets (ROA)	-	-	-28.39%	-31.72%	-24.01%	-15.62%
Return on Capital Employed (ROCE)	-70.20%	-70.60%	-50.30%	-60.50%	-52.10%	-29.80%
Earnings Yield	-35.55%	-47.64%	-26.96%	-45.20%	-32.17%	-15.83%
FCF Yield	-37.88%	-57.20%	-33.03%	-40.79%	-38.72%	-18.74%
Buyback Yield / Dilution	-	-	-87.22%	-18.72%	-	-13.05%